Akorn Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2020, Akorn Inc's inventory turnover ratio sequentially decreased to 2.34 in the second quarter 2020, unsurprisingly, as the Akorn Inc markets continue to deteriorate, and AKRXQ's faces growing challenges to bring down its inventories. Akorn Inc's average inventory processing period in the Jun 30 2020 quarter, has increased to 156 days, from 144 days, in the Mar 31 2020 quarter.

Within Healthcare sector 215 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1503 in the first quarter 2020, to 1575.

AKRXQ Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Akorn Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AKRXQ Inventory Turnover Ratio	(Jun 30 2020) II. Quarter	(Mar 31 2020) I. Quarter	(Dec 31 2019) IV. Quarter	(Sep 30 2019) III. Quarter	(Jun 30 2019) II. Quarter
Y / Y Inventory Growth	13.89 %	6.05 %	-2.07 %	-13.9 %	-14.89 %
Y / Y Cost of Sales Growth	-18.91 %	-1.97 %	-20.05 %	-3.25 %	0.37 %
Inventory Turnover Ratio (TTM)	2.34	2.54	2.59	2.73	2.65
AKRXQ's Total Ranking	# 1575	# 1503	# 1577	# 1575	# 1575
Average inventory processing period	156	144	141	134	138
Seq. Inventory Growth	7.29 %	1.5 %	1.4 %	3.14 %	-0.1 %
Seq. Cost of Sales Growth	-18.97 %	7.51 %	-2.28 %	-4.75 %	-2.03 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 68
Healthcare Sector	# 216
Overall Market	# 1575

Inventory Turnover Ratio Statistics
High	Average	Low
2.73	2.41	1.64
(Sep 30 2019)		(Jun 30 2012)

AKRXQ Company Profile >> Back to AKRXQ Efficiency Comparisons >> Compare AKRXQ Inventory Turnover Ratio to its Competitors

Financial Statements
Akorn Inc's Inventories	$ 185 Millions	Visit AKRXQ's Balance sheet
Akorn Inc's Cost of Revenues TTM	$ 407 Millions	Visit AKRXQ's Income Statement
What are AKRXQ's Sales?		Visit AKRXQ's Sales by Segment

Other Inventory Turnover Ratios
Akorn Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
AKRXQ's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for AKRXQ's Competitors
Inventory Turnover Ratio for AKRXQ's Suppliers
Inventory Turnover Ratio for AKRXQ's Customers

You may also want to know
AKRXQ's Sales Growth Rates	AKRXQ's Pe Price to earnings ratio	AKRXQ's Receivables Turnover Ratio	AKRXQ's Stock Quote
AKRXQ's Net Income Growth Rates	AKRXQ's Ps Price to Sales ratio	AKRXQ's Sales per Employee	AKRXQ's Asset Turnover Ratio
AKRXQ's Net Margin	AKRXQ's Pb Price to Book ratio	AKRXQ's Financial Strength Ratios	AKRXQ's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2020, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2020	Inventories at quarter ending Jun 30 2020
Twist Bioscience Corporation	5.81	$ 56.214 Millions	$ 10 Millions
Lantheus Holdings Inc	5.78	$ 181.832 Millions	$ 31 Millions
Stablecoin Development Corporation	5.77	$ 3.615 Millions	$ 1 Millions
Avantor Inc	5.71	$ 4,064.800 Millions	$ 712 Millions
Aquestive Therapeutics Inc	5.63	$ 18.633 Millions	$ 3 Millions
Bionexus Gene Lab Corp	5.49	$ 0.066 Millions	$ 0 Millions
Patterson Companies Inc	5.36	$ 4,246.025 Millions	$ 792 Millions
Myriad Genetics Inc	5.28	$ 157.500 Millions	$ 30 Millions
Vericel Corporation	5.25	$ 38.491 Millions	$ 7 Millions
Camp4 Therapeutics Corporation	5.25	$ 218.307 Millions	$ 42 Millions
West Pharmaceutical Services Inc	5.17	$ 1,282.300 Millions	$ 248 Millions
Hill rom Holdings Inc	5.12	$ 1,454.500 Millions	$ 284 Millions
Inogen Inc	5.09	$ 182.506 Millions	$ 36 Millions
Idexx Laboratories Inc	5.06	$ 1,063.875 Millions	$ 210 Millions
Adm Tronics Unlimited Inc	5.03	$ 1.917 Millions	$ 0 Millions
Gw Pharmaceuticals Plc	5.03	$ 34.925 Millions	$ 7 Millions
Mallinckrodt Plc	4.99	$ 1,619.900 Millions	$ 324 Millions
Sintx Technologies Inc	4.99	$ 0.668 Millions	$ 0 Millions
Gilead Sciences Inc	4.95	$ 4,751.000 Millions	$ 961 Millions
Invacare Holdings Corporation	4.93	$ 628.243 Millions	$ 127 Millions
Global Cord Blood Corp	4.86	$ 33.293 Millions	$ 7 Millions
Cytosorbents Corporation	4.81	$ 9.426 Millions	$ 2 Millions
Eagle Pharmaceuticals inc	4.80	$ 36.173 Millions	$ 8 Millions
Henry Schein Inc	4.72	$ 6,518.880 Millions	$ 1,380 Millions
Alimera Sciences Inc	4.69	$ 7.264 Millions	$ 2 Millions
Integrated Biopharma Inc	4.68	$ 46.042 Millions	$ 10 Millions
Htg Molecular Diagnostics Inc	4.63	$ 6.348 Millions	$ 1 Millions
Endo International Plc	4.58	$ 1,514.116 Millions	$ 330 Millions
Neuronetics Inc	4.55	$ 13.545 Millions	$ 3 Millions
Dexcom Inc	4.52	$ 619.200 Millions	$ 137 Millions

Date modified: 2026-08-29T17:34:59+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.